Products
Latest News
FAQ
|
Search
Search
Filters
Clear All
Study Phase
Early Phase 1
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
Phase 4
Not Applicable
Recruitment Status
Recruiting
Not yet recruiting
Active, not recruiting
Completed
Suspended
Terminated
Withdrawn
Study Type
Interventional
Observational
Expanded Access
Others
Eligibility Sex
All
Female
Male
Healthy Volunteers
All
Include
Exclude
Found
1
clinical trials
|
View Analysis
Sort by:
Newest First
THEMBA II T-Cell Vaccine: Vaccination With saRNA COVID-19 Vaccines
Phase 1
Terminated
Conditions
COVID-19
Interventions
Biological: AAHI-SC2 Vaccine
Biological: AAHI-SC3 Vaccine
Biological: EUA or approved vaccine
Subscribe
First Posted Date
2022-05-11
Last Posted Date
2024-05-01
Lead Sponsor
ImmunityBio, Inc.
Target Recruit Count
60
Registration Number
NCT05370040
Locations
🇿🇦
Wits Vida, Johannesburg, South Africa
Subscribe
Prev
1
Next
© Copyright 2025. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy